Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Hill-Rom (HRC) stocks in Canada

Learn how to easily invest in Hill-Rom stocks.

Hill-Rom is a medical instruments & supplies business based in the US. Hill-Rom stocks (HRC.US) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $117.14 – the same closing value as a week prior. Hill-Rom employs 10,000 staff and has a trailing 12-month revenue of around $3 billion.

How to buy shares in Hill-Rom

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – HRC – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Hill-Rom stock price (NYSE:HRC)

Use our graph to track the performance of HRC stocks over time.

Hill-Rom shares at a glance

Information last updated 2022-01-23.
Latest market close$155.96
52-week range$92.79 - $156.22
50-day moving average $154.34
200-day moving average $130.22
Wall St. target price$156.00
PE ratio 41.9247
Dividend yield $0.94 (0.62%)
Earnings per share (TTM) $3.72

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
Wealthsimple Trade
Finder Rating:
3.9 / 5
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
3.8 / 5
$4.99 - $9.99
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
4.1 / 5
Min. $1.00, Max. 0.5%
Stocks, Bonds, Options, ETFs, Currencies, Futures
CIBC Investor's Edge
Finder Rating:
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Finder Rating:
4.2 / 5
$4.95 - $9.95
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get up to $5,000 cash back. Conditions apply. Offer ends March 1, 2022.

Compare up to 4 providers

Online stock trading

Is it a good time to buy Hill-Rom stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Hill-Rom price performance over time

Historical closes compared with the close of $155.96 from 2021-12-13

1 week (2022-01-17) N/A
1 month (2021-12-24) N/A
3 months (2021-10-28) 0.74%
6 months (2021-07-28) 17.58%
1 year (2021-01-28) 56.96%
2 years (2020-01-28) 44.02%
3 years (2019-01-28) 56.35%
5 years (2017-01-27) 161.55%

Is Hill-Rom under- or over-valued?

Valuing Hill-Rom stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Hill-Rom's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Hill-Rom's P/E ratio

Hill-Rom's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 42x. In other words, Hill-Rom shares trade at around 42x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Hill-Rom's PEG ratio

Hill-Rom's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.71. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Hill-Rom's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Hill-Rom's EBITDA

Hill-Rom's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $645.3 million.

The EBITDA is a measure of a Hill-Rom's overall financial performance and is widely used to measure a its profitability.

Hill-Rom financials

Revenue TTM $3 billion
Operating margin TTM 15.7%
Gross profit TTM $1.6 billion
Return on assets TTM 6.13%
Return on equity TTM 13.78%
Profit margin 8.23%
Book value $28.53
Market capitalisation $10.3 billion

TTM: trailing 12 months

Hill-Rom share dividends


Dividend payout ratio: 15.21% of net profits

Recently Hill-Rom has paid out, on average, around 15.21% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.62% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Hill-Rom shareholders could enjoy a 0.62% return on their shares, in the form of dividend payments. In Hill-Rom's case, that would currently equate to about $0.94 per share.

While Hill-Rom's payout ratio might seem low, this can signify that Hill-Rom is investing more in its future growth.

Hill-Rom's most recent dividend payout was on 30 December 2021. The latest dividend was paid out to all shareholders who bought their shares by 13 December 2021 (the "ex-dividend date").

Have Hill-Rom's shares ever split?

Hill-Rom's shares were split on a 2:1 basis on 1 March 1992. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Hill-Rom shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Hill-Rom shares which in turn could have impacted Hill-Rom's share price.

Hill-Rom share price volatility

Over the last 12 months, Hill-Rom's shares have ranged in value from as little as $92.7877 up to $156.22. A popular way to gauge a stock's volatility is its "beta".

HRC.US volatility(beta: 0.55)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Hill-Rom's is 0.5532. This would suggest that Hill-Rom's shares are less volatile than average (for this exchange).

Hill-Rom overview

Hill-Rom Holdings, Inc. operates as a medical technology company worldwide. The company operates through Patient Support Systems, Front Line Care, and Surgical Solutions segments. It offers medical surgical beds, intensive care unit beds, and bariatric patient beds, patient mobility solutions, non-invasive therapeutic products and surfaces, and information technologies and software solutions, as well as sells equipment service contracts for its capital equipment. The company also provides patient monitoring and diagnostics products, such as patient exam and diagnostics, patient monitoring, diagnostic cardiology, vision screening, and diagnostics products; and respiratory health products comprising non-invasive devices that provide respiratory support and assist patients in the mobilization of retained blockages. In addition, it offers surgical solutions that include tables, lights, and pendants; and positioning devices for use in shoulder, hip, spinal, and lithotomy surgeries, as well as platform-neutral positioning accessories for operating room tables. Further, the company sells and rents products to acute and extended care facilities through direct sales force and distributors; sells and rents products directly to patients in the home; and sells products to primary care facilities through distributors.

Hill-Rom in the news

There are no recent company news

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site